Kewaunee Scientific (NASDAQ:KEQU) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $47.48 and traded as high as $66.04. Kewaunee Scientific shares last traded at $60.40, with a volume of 21,250 shares trading hands.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research note on Wednesday, December 18th.

Kewaunee Scientific Stock Performance

The firm's 50 day moving average is $61.01 and its two-hundred day moving average is $47.70. The stock has a market capitalization of $159.43 million, a PE ratio of 8.80 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, December 11th. The technology company reported $1.41 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Insider Buying and Selling

In other Kewaunee Scientific news, VP Elizabeth D. Phillips sold 1,850 shares of the stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total value of $100,214.50. Following the sale, the vice president now directly owns 13,591 shares of the company's stock, valued at approximately $736,224.47. This represents a 11.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Thomas David Hull III sold 2,000 shares of the stock in a transaction that occurred on Thursday, December 26th. The shares were sold at an average price of $63.01, for a total transaction of $126,020.00. Following the completion of the sale, the chief executive officer now directly owns 42,497 shares in the company, valued at approximately $2,677,735.97. This represents a 4.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,994 shares of company stock valued at $729,430 in the last ninety days. Company insiders own 14.20% of the company's stock.

Institutional Investors Weigh In On Kewaunee Scientific

A number of large investors have recently modified their holdings of the company. Bank of America Corp DE increased its position in shares of Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after purchasing an additional 443 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of Kewaunee Scientific in the 4th quarter valued at $300,000. Marshall Wace LLP acquired a new position in shares of Kewaunee Scientific in the 4th quarter valued at $736,000. Invesco Ltd. acquired a new position in shares of Kewaunee Scientific in the 4th quarter valued at $6,545,000. Finally, Wedbush Securities Inc. acquired a new position in shares of Kewaunee Scientific in the 4th quarter valued at $262,000. 32.69% of the stock is owned by hedge funds and other institutional investors.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.